Search
Now showing items 21-30 of 402
Parkinson disease: Serotonin reuptake inhibitors for depression in PD
(Nature Publishing Group, 2012-07)
A recent study to investigate the safety and efficacy of serotonin reuptake inhibitors suggests that these drugs are beneficial for the treatment of depressive disorders in Parkinson disease. Whether these treatments will ...
Síndrome Serotoninérgico
(Universidad de Costa Rica, 2019)
Neonatal exposure to citalopram, a serotonin selective reuptake inhibitor, programs a delay in the reflex ontogeny in rats
(Associa????o Arquivos de Neuro-Psiquiatria Dr. Oswaldo Lange, 2008)
Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial
(PERGAMON-ELSEVIER SCIENCE LTDOXFORD, 2012)
Clinical effectiveness of group cognitive-behavioral therapy (GCBT) versus fluoxetine in obsessive-compulsive disorder outpatients that could present additional psychiatric comorbidities was assessed. Patients (18-65 years; ...
Efeito dos inibidores de recaptação da serotonina na plasticidade neural após acidente vascular cerebral
(2015-06-30)
Introduction. Recently, selective serotonin reuptake inhibitors (SSRIs) have been highlighted as neuroplasticity agents for improving functional and motor recuperation in patients after stroke. Objective. Considering the ...
In vitro synergistic effects of fluoxetine and paroxetine in combination with amphotericin B against Cryptococcus neoformans
(2021-03-01)
Cryptococcus neoformans is a yeast that mainly affects immunocompromised individuals and causes meningoencephalitis depending on the immune status of the host. The present study aimed to validate the efficacy of selective ...
Mice lacking the serotonin 5-HT2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants
(Elsevier Science, 2016-02)
Depressive disorders are among the most prevalent neuropsychiatric dysfunctions worldwide, with high rates of resistance to antidepressant treatment. Genetic factors clearly contribute to the manifestation of depression ...
Acute fluoxetine administration differentially affects brain C-Fos expression in fasted and refed rats
(Elsevier, 2005)
In the present study we investigated the effect of acute fluoxetine administration on the expression of c-Fos in the rat brain under two different metabolic conditions: fed and fasting states. Wistar male rats, weighing ...